Abstract:Objective To observe the expression of Her-2/neu protein and androgen receptor (AR) in human prostate cancer and to evaluate their significances in the progression of prostate cancer. Methods The Her-2/neu protein and AR immunohistochemical stain were carried out in human prostate tissue microarray that consisted of prostate cancer (107 cases) and benign prostate tissue (42 cases). The prostate cancer cases were divided into 4 groups: group one (Gleason score 6),group two (Gleasonscore 7), group three (Gleasonscore 8) and group four (Gleasonscore 9) according to the Gleason score. The immunostains immunohistochemical stain were interpreted in two aspects of the staining intensity and the percentage of positive cells. The significance and relationships between the expression of Her-2/neu protein and AR in prostate cancer and benign prostate tissue (BPT) and the grouping of different Gleason scores of prostate cancer were then evaluated. Results The positive expression rate of Her-2/neu protein was significantly higher in prostate cancer tissue than in BPT [43.9%(47/107) vs. 14.3%(6/42), x2=11.562, P=0.009], and the positive expression intensity of Her-2/neu immunoreactivity was also higher (x2= 11.764, P=0.008). There were significant differences in positive expression intensity of Her-2/neu immunoreactivity among the different Gleason scores groups (x2 = 20. 512, P = 0. 015), and the expression intensity was significantly positively correlated with Gleason scores ( r= 0. 269, P = 0. 005). There was significant difference in AR immunoreactivity between in prostate cancer (67 %, 72/107) and in BPT (50 %, 21/42, x2 =3. 843, P=0. 050). Among prostate cancer cases, the positive expression intensity of AR was not significantly different among groups 1 through 4 (x2 = 4. 318, P = 0. 229), and was not significantly correlated with Gleason scores ( r = - 0. 065, P = 0. 505 ). Moreover, the positive expression intensity of Her-2/neu protein was not significantly correlated with that of AR (r = -0. 115, P=0. 237). Conclusions Overexpression of Her-2/neu protein in human prostate cancer tissue suggests that Her-2/neu may have some role in prostate tumorigenesis. Her-2/neu protein expression is positively correlated with Gleason score in prostate cancer, which suggests that Her-2/neu may be a potential prognostic predictor of prostate cancer.

Expression of BRMS1 gene in prostate cancer and its clinical significance

Expression of BRG1 and BRM Proteins in Prostatic Cancer

Detection of aberrant methylation of RARβ2, GSTP1 and DAPK gene in prostate cancer and its clinical significance

Expression and clinical significance of Bmi-1 in colorectal cancer

[Association of Bmi-1 Expression with Clinicopathological Features and Prognosis of Colorectal Cancer].

Expression of LSD1 and AR in Prostate Cancer and Its Clinical Significance

BRG1 Expression in Prostate Carcinoma by Application of Tissue Microarray

Expressions of Shh and Stathmin in Prostatic Diseases and Their Clinical Significances

The expression and clinical significance of MS4A8B in prostate cancer tissue

Correlation Between Molecular Biomarkers and Risk Factors for the Clinical Progression of Benign Prostatic Hyperplasia Using Tissue Micro Array Immuno Staining

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Overexpression Levels of Cripto-1 Predict Poor Prognosis in Patients with Prostate Cancer Following Radical Prostatectomy

Clinical significance of TMPRSS4 in prostate cancer.

Association study of SIRT1 expression with benign prostatic hyperplasia

Expression and its significance of Her-2/neu protein and androgen receptor in human prostate cancer

[Expression of Glycoprotein Non-Metastatic Melanoma Protein B in Prostate Cancer and Its Significance].

Expression of Nucleosomal Binding Protein 1 in Normal Prostate Benign Prostate Hyperplasia, and Prostate Cancer and Significance Thereof

Clinical significance of TMPRSS 4 in prostate cancer

Expression of Breast Cancer Metastasis Suppressor-1, BRMS-1, in Human Breast Cancer and the Biological Impact of BRMS-1 on the Migration of Breast Cancer Cells.

The expressions and clinical significances of AR in prostate carcinoma

[P53 Expression and Its Clinical Significance in Prostatic Carcinoma].